Magnolia Grabs Further FDA Clearance for Blood Collection System

Magnolia Medical said it has received 510(k) clearance for the second generation of its Steripath blood culture diversion device.

The system is indicated for reducing blood culture contamination, mechanically diverting and sequestering the initial 1.5-2.0 mL of a blood sample to separate any contaminants.

After diverting that amount of blood, the device collects the blood culture through a secondary flow path.